# Study of the Activity of PD-1 Inhibitors in Metastatic Uveal Melanoma

> **NCT03964298** · — · COMPLETED · sponsor: **Institut Curie** · enrollment: 100 (actual)

## Conditions studied

- Uveal Melanoma

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT03964298
- **Lead sponsor:** Institut Curie
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2016-11
- **Primary completion:** 2019-11
- **Final completion:** 2020-12
- **Target enrollment:** 100 (ACTUAL)
- **Last updated:** 2025-08-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03964298

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03964298, "Study of the Activity of PD-1 Inhibitors in Metastatic Uveal Melanoma". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT03964298. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*